The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
MD-Logic Artificial Pancreas System
Open accessAbstract
OBJECTIVE: Current state-of-the-art artificial pancreas systems are either based on traditional linear control theory or rely on mathematical models of glucose-insulin dynamics. Blood glucose control using these methods is limited due to the complexity of the biological system. The aim of this study was to describe the principles and clinical performance of the novel MD-Logic Artificial Pancreas (MDLAP) System. RESEARCH DESIGN AND METHODS: The MDLAP applies fuzzy logic theory to imitate lines of reasoning of diabetes caregivers. It uses a combination of control-to-range and control-to-target strategies to automatically regulate individual glucose levels. Feasibility clinical studies were conducted in seven adults with type 1 diabetes (aged 19–30 years, mean diabetes duration 10 ± 4 years, mean A1C 6.6 ± 0.7%). All underwent 14 full, closed-loop control sessions of 8 h (fasting and meal challenge conditions) and 24 h. RESULTS: The mean peak postprandial (overall sessions) glucose level was 224 ± 22 mg/dl. Postprandial glucose levels returned to <180 mg/dl within 2.6 ± 0.6 h and remained stable in the normal range for at least 1 h. During 24-h closed-loop control, 73% of the sensor values ranged between 70 and 180 mg/dl, 27% were >180 mg/dl, and none were <70 mg/dl. There were no events of symptomatic hypoglycemia during any of the trials. CONCLUSIONS: The MDLAP system is a promising tool for individualized glucose control in patients with type 1 diabetes. It is designed to minimize high glucose peaks while preventing hypoglycemia. Further studies are planned in the broad population under daily-life conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
Hovorka, R., Canonico, V., Chassin, L. J., Haueter, U., Massi-Benedetti, M., Federici, M. O., Pieber, T. R., Schaller, H. C., Schaupp, L., Vering, T., et al. (2004) · Physiological Measurement · doi:10.1088/0967-3334/25/4/010 · Cited by 1,274
Fuzzy Systems Engineering: Toward Human‐Centric Computing
Pedrycz, W., & Gomide, F. (2007) · Wiley eBooks · doi:10.1002/9780470168967 · Cited by 507
A model-based algorithm for blood glucose control in Type I diabetic patients
Parker, R. S., Doyle, F. J., & Peppas, N. A. (1999) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.740877 · Cited by 500
Model Predictive Control of Type 1 Diabetes: An in Silico Trial
Magni, L., Raimondo, D. M., Bossi, L., Dalla Man, C., De Nicolao, G., Kovatchev, B., & Cobelli, C. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100603 · Cited by 317
Closed-loop insulin delivery—the path to physiological glucose control
Steil, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.011 · Cited by 313
Evaluating the Efficacy of Closed-Loop Glucose Regulation via Control-Variability Grid Analysis
Magni, L., Raimondo, D. M., Man, C. D., Breton, M., Patek, S., De Nicolao, G., Cobelli, C., & Kovatchev, B. P. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200414 · Cited by 207
Closing the Loop: The Adicol Experience
Hovorka, R., Chassin, L. J., Wilinska, M. E., Canonico, V., Akwi, J. A., Federici, M. O., Massi‐Benedetti, M., Hutzli, I., Zaugg, C., Kaufmann, H., et al. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504774197990 · Cited by 162
Modular Artificial β-Cell System: A Prototype for Clinical Research
Dassau, E., Zisser, H., Palerm, C. C., Buckingham, B. A., Jovanovic, L. G., & Doyle, F. J. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200518 · Cited by 80
A new approach to diabetic control: Fuzzy logic and insulin pump technology
Grant, P. S. (2006) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2006.08.014 · Cited by 76
A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics
Ibbini, M., & Masadeh, M. M. (2005) · Journal of Medical Engineering & Technology · doi:10.1080/03091900410001709088 · Cited by 69
Heart rate variability and circadian variations in type 1 diabetes mellitus
Kardelen, F., Akçurin, G., Ertuğ, H., Akçurin, S., & Bircan, İ. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2006.00141.x · Cited by 62
Dassau, E., Palerm, C. C., Zisser, H., Buckingham, B. A., Jovanovič, L., & Doyle, F. J. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0055 · Cited by 38
Shalitin, S., & Phillip, M. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2006.00170.x · Cited by 23
Self-citation
Cited by
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Artificial intelligence for diabetes management and decision support: Literature review
Contreras, I., & Vehi, J. (2018) · Journal of Medical Internet Research · doi:10.2196/10775 · Cited by 560
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Metadata
- Authors
- Atlas, E., Nimri, R., Miller, S., Grunberg, E. A., & Phillip, M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-02-11
- Volume
- 33
- Issue
- 5
- Pages
- 1072-1076
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2160052863
- Cited by
- 266
- References
- 13
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.